Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker VCYT
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | Karin Eastham Director | VCYT Veracyte, Inc. | 14,850 | $715.8K | 10b5-1 | Oct 27, 2026 | Form 4 ↗ 1 day later · 14,850 shares | Form 144 ↗ |
| Oct 27, 2026 | Jens Holstein Director | VCYT Veracyte, Inc. | 7,500 | $375.0K | 10b5-1 | Oct 27, 2026 | Form 4 ↗ 1 day later · 7,500 shares | Form 144 ↗ |
| Sep 24, 2026 | Jens Holstein Director | VCYT Veracyte, Inc. | 7,500 | $352.5K | 10b5-1 | Sep 24, 2026 | Form 4 ↗ 34 days later · 15,000 shares | Form 144 ↗ |
| Sep 21, 2026 | John Leite Officer | VCYT Veracyte, Inc. | 4,015 | $159.8K | 10b5-1 | Sep 21, 2026 | Form 4 ↗ 1 day later · 4,015 shares | Form 144 ↗ |
| Sep 14, 2026 | Jens Holstein Director | VCYT Veracyte, Inc. | 5,000 | $204.7K | 10b5-1 | Sep 14, 2026 | Form 4 ↗ 2 days later · 5,000 shares | Form 144 ↗ |
| Sep 4, 2026 | Ann McGuire Officer | VCYT Veracyte, Inc. | 3,254 | $145.4K | 10b5-1 | Sep 4, 2026 | Form 4 ↗ same day · 3,254 shares | Form 144 ↗ |
| Sep 4, 2026 | Rebecca Chambers Officer | VCYT Veracyte, Inc. | 3,652 | $163.1K | 10b5-1 | Sep 4, 2026 | Form 4 ↗ same day · 3,652 shares | Form 144 ↗ |
| Sep 4, 2026 | Phillip Febbo Officer | VCYT Veracyte, Inc. | 13,110 | $585.6K | 10b5-1 | Sep 4, 2026 | Form 4 ↗ same day · 13,110 shares | Form 144 ↗ |
| Sep 1, 2026 | Muna Bhanji Director | VCYT Veracyte, Inc. | 3,728 | $161.0K | 10b5-1 | Sep 1, 2026 | Form 4 ↗ 2 days later · 1,864 shares | Form 144 ↗ |
| Jun 18, 2026 | Karin Eastham Director | VCYT Veracyte, Inc. | 3,729 | $191.3K | 10b5-1 | Jun 18, 2026 | Form 4 ↗ 4 days later · 3,729 shares | Form 144 ↗ |
| Jun 4, 2026 | Ann McGuire Officer | VCYT Veracyte, Inc. | 3,176 | $154.6K | 10b5-1 | Jun 4, 2026 | Form 4 ↗ same day · 3,176 shares | Form 144 ↗ |
| Jun 4, 2026 | John Leite Officer | VCYT Veracyte, Inc. | 13,975 | $680.4K | 10b5-1 | Jun 4, 2026 | Form 4 ↗ same day · 13,975 shares | Form 144 ↗ |
| Jun 4, 2026 | Marc Stapley Director, Officer | VCYT Veracyte, Inc. | 138,051 | $6.7M | 10b5-1 | Jun 4, 2026 | Form 4 ↗ same day · 138,051 shares | Form 144 ↗ |
| Jun 4, 2026 | Rebecca Chambers Officer | VCYT Veracyte, Inc. | 3,561 | $173.4K | 10b5-1 | Jun 4, 2026 | Form 4 ↗ same day · 3,561 shares | Form 144 ↗ |
| May 20, 2026 | Robert Epstein Director | VCYT Veracyte, Inc. | 10,000 | $416.9K | 10b5-1 | May 20, 2026 | Form 4 ↗ 2 days later · 10,000 shares | Form 144 ↗ |
| May 6, 2026 | Ann McGuire Officer | VCYT Veracyte, Inc. | 10,204 | $336.4K | 10b5-1 | May 6, 2026 | Form 4 ↗ 2 days later · 10,204 shares | Form 144 ↗ |
| Mar 4, 2026 | Ann McGuire Officer | VCYT Veracyte, Inc. | 6,658 | $233.6K | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 6,658 shares | Form 144 ↗ |
| Mar 4, 2026 | John Leite Officer | VCYT Veracyte, Inc. | 5,260 | $184.5K | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 5,260 shares | Form 144 ↗ |
| Mar 4, 2026 | Rebecca Chambers Officer | VCYT Veracyte, Inc. | 18,341 | $643.4K | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 18,341 shares | Form 144 ↗ |
| Mar 4, 2026 | Marc Stapley Director, Officer | VCYT Veracyte, Inc. | 45,523 | $1.6M | 10b5-1 | Mar 4, 2026 | Form 4 ↗ 2 days later · 45,523 shares | Form 144 ↗ |
| Mar 2, 2026 | Phillip Febbo Officer | VCYT Veracyte, Inc. | 13,425 | $491.2K | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 2 days later · 13,425 shares | Form 144 ↗ |
| Dec 16, 2025 | Ann McGuire Officer | VCYT Veracyte, Inc. | 10,739 | $467.5K | 10b5-1 | Dec 16, 2025 | Form 4 ↗ 1 day later · 10,739 shares | Form 144 ↗ |
| Dec 5, 2025 | Karin Eastham Director | VCYT Veracyte, Inc. | 20,000 | $948.2K | 10b5-1 | Dec 5, 2025 | Form 4 ↗ 3 days later · 20,000 shares | Form 144 ↗ |
| Dec 4, 2025 | Ann McGuire Officer | VCYT Veracyte, Inc. | 1,422 | $67.9K | 10b5-1 | Dec 4, 2025 | Form 4 ↗ same day · 1,422 shares | Form 144 ↗ |
| Dec 4, 2025 | Rebecca Chambers Officer | VCYT Veracyte, Inc. | 13,278 | $634.0K | 10b5-1 | Dec 4, 2025 | Form 4 ↗ same day · 13,278 shares | Form 144 ↗ |
| Dec 4, 2025 | Marc Stapley Director, Officer | VCYT Veracyte, Inc. | 7,668 | $366.1K | 10b5-1 | Dec 4, 2025 | Form 4 ↗ same day · 7,668 shares | Form 144 ↗ |
| Nov 25, 2025 | Evan Jones Director | VCYT Veracyte, Inc. | 5,000 | $246.9K | 10b5-1 | Nov 25, 2025 | Form 4 ↗ 1 day later · 1,106 shares | Form 144 ↗ |
| Nov 25, 2025 | John Leite Officer | VCYT Veracyte, Inc. | 4,086 | $190.8K | 10b5-1 | Nov 25, 2025 | Form 4 ↗ 1 day later · 2,808 shares | Form 144 ↗ |
| Nov 20, 2025 | Jens Holstein Director | VCYT Veracyte, Inc. | 10,000 | $423.6K | 10b5-1 | Nov 20, 2025 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Nov 5, 2025 | Evan Jones Director | VCYT Veracyte, Inc. | 43,196 | $2.0M | 10b5-1 | Nov 5, 2025 | Form 4 ↗ 2 days later · 43,196 shares | Form 144 ↗ |
| Nov 5, 2025 | Karin Eastham Director | VCYT Veracyte, Inc. | 9,674 | $349.4K | 10b5-1 | Nov 5, 2025 | Form 4 ↗ 2 days later · 9,674 shares | Form 144 ↗ |
| Nov 5, 2025 | Ann McGuire Officer | VCYT Veracyte, Inc. | 6,466 | $233.6K | 10b5-1 | Nov 5, 2025 | Form 4 ↗ 2 days later · 6,466 shares | Form 144 ↗ |
| Nov 5, 2025 | Rebecca Chambers Officer | VCYT Veracyte, Inc. | 7,000 | $252.8K | 10b5-1 | Nov 5, 2025 | Form 4 ↗ 2 days later · 7,000 shares | Form 144 ↗ |
| Oct 6, 2025 | Phillip Febbo Officer | VCYT Veracyte, Inc. | 8,349 | $300.6K | 10b5-1 | Oct 6, 2025 | Form 4 ↗ 1 day later · 8,349 shares | Form 144 ↗ |
| Oct 1, 2025 | Robert S Epstein Director | VCYT Veracyte, Inc. | 21,473 | $737.2K | 10b5-1 | Oct 1, 2025 | Form 4 ↗ 2 days later · 21,473 shares | Form 144 ↗ |
| Oct 1, 2025 | John Leite Officer | VCYT Veracyte, Inc. | 2,539 | $87.2K | 10b5-1 | Oct 1, 2025 | Form 4 ↗ 2 days later · 2,539 shares | Form 144 ↗ |
| Oct 1, 2025 | Ann McGuire Officer | VCYT Veracyte, Inc. | 2,160 | $74.2K | 10b5-1 | Oct 1, 2025 | Form 4 ↗ 2 days later · 2,160 shares | Form 144 ↗ |
| Sep 19, 2025 | Ann McGuire Officer | VCYT Veracyte, Inc. | 2,283 | $75.9K | 10b5-1 | Sep 19, 2025 | Form 4 ↗ 4 days later · 2,283 shares | Form 144 ↗ |
| Sep 4, 2025 | Marc Stapley Director, Officer | VCYT Veracyte, Inc. | 7,667 | $234.8K | 10b5-1 | Sep 4, 2025 | Form 4 ↗ 4 days later · 7,667 shares | Form 144 ↗ |
| Jun 13, 2025 | Karin Eastham Director | VCYT Veracyte, Inc. | 4,590 | $122.5K | 10b5-1 | Jun 13, 2025 | Form 4 ↗ 4 days later · 4,590 shares | Form 144 ↗ |
| Jun 13, 2025 | Muna Bhanji Director | VCYT Veracyte, Inc. | 4,589 | $122.5K | 10b5-1 | Jun 13, 2025 | Form 4 ↗ 4 days later · 4,589 shares | Form 144 ↗ |
| Jun 4, 2025 | John Leite Officer | VCYT Veracyte, Inc. | 2,809 | $74.4K | 10b5-1 | Jun 4, 2025 | Form 4 ↗ 2 days later · 2,809 shares | Form 144 ↗ |
| Mar 7, 2025 | John Leite Officer | VCYT Veracyte, Inc. | 7,411 | $240.9K | 10b5-1 | Mar 7, 2025 | Form 4 ↗ 3 days later · 7,411 shares | Form 144 ↗ |
| Mar 4, 2025 | Ann McGuire Officer | VCYT Veracyte, Inc. | 1,142 | $38.3K | 10b5-1 | Mar 4, 2025 | Form 4 ↗ 2 days later · 1,142 shares | Form 144 ↗ |
| Mar 4, 2025 | Marc Stapley Director, Officer | VCYT Veracyte, Inc. | 52,697 | $1.8M | 10b5-1 | Mar 4, 2025 | Form 4 ↗ 2 days later · 52,697 shares | Form 144 ↗ |
| Mar 4, 2025 | Phillip Febbo Officer | VCYT Veracyte, Inc. | 8,037 | $269.7K | 10b5-1 | Mar 4, 2025 | Form 4 ↗ 2 days later · 8,037 shares | Form 144 ↗ |
| Jan 2, 2025 | Karin Eastham Director | VCYT Veracyte, Inc. | 10,000 | $396.0K | 10b5-1 | Jan 2, 2025 | Form 4 ↗ 4 days later · 10,000 shares | Form 144 ↗ |
| Dec 13, 2024 | Marc Stapley Director, Officer | VCYT Veracyte, Inc. | 5,590 | $248.2K | 10b5-1 | Dec 13, 2024 | Form 4 ↗ 4 days later · 5,590 shares | Form 144 ↗ |
| Dec 5, 2024 | Phillip G Febbo Officer | VCYT Veracyte, Inc. | 1,311 | $57.8K | 10b5-1 | Dec 4, 2024 | Form 4 ↗ 91 days later · 8,037 shares | Form 144 ↗ |
| Dec 4, 2024 | Phillip G Febbo Officer | VCYT Veracyte, Inc. | 2,623 | $114.5K | 10b5-1 | Dec 4, 2024 | Form 4 ↗ 2 days later · 3,934 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:36 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances